VA National Clinical Public Health Programs — HIV/AIDSwww.hiv.va.gov | Disclaimer: This information is not meant to substitute for professional advice; please consult your medical provider or pharmacist. Viramune
(nevirapine)
Type of Drug: Nonnucleoside Reverse Transcriptase Inhibitor (NNRTI, nonnucleoside, "nonnuke") Note: To reduce side effects when starting this medication, patients should take one 200 mg pill daily for the first 14 days, and then follow the schedule below. Notes on taking this medication- No food restrictions, can take with or without food
- Viramune interacts with many other drugs; persons using Viramune with those drugs may need an adjustment to their dose of the other drugs or avoid certain combinations; consult your medical provider
Side effects- Rash: rarely, rash may be severe and may require hospitalization; rash usually appears within first 3 weeks of starting drug
- Liver inflammation; rarely severe liver damage; liver test results should be monitored closely for the first 18 weeks that you take Viramune
- Nausea; abdominal discomfort
| |
|
|